A514 (Divalproex Sodium Delayed Release 500 mg)

Pill with imprint A514 is Yellow, Elliptical / Oval and has been identified as Divalproex Sodium Delayed Release 500 mg. It is supplied by Anchen Pharmaceuticals, Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A514

Divalproex Sodium Delayed Release

Imprint

A514

Strength

500 mg

Color

Yellow

Size

19.00 mm

Shape

Elliptical / Oval

Availability

Prescription only

Drug Class

Fatty acid derivative anticonvulsants

Pregnancy Category

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine

CSA Schedule

Not a controlled drug

Labeler / Supplier

Anchen Pharmaceuticals, Inc.

National Drug Code (NDC)

24979-0514

Inactive Ingredients

silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, povidone, magnesium silicate, titanium dioxide, triethyl citrate, FD&C Yellow No. 5, ferric oxide red, cellacefate

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "A514"

Edarbi

Dallergy PSE

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer